Phase I trial of low-dose oral sodium nitrite (TV 1001) in patients with diabetes mellitus and peripheral arterial disease.
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2011
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Diabetic angiopathies; Peripheral arterial disorders
- Focus Adverse reactions; Pharmacokinetics
- 22 Sep 2011 New trial record
- 20 Sep 2011 Interim results reported in a TheraVasc media release.